[Persistent microbial infection and therapeutic vaccine]

Area of Science:

• Immunology
• Microbiology
• Vaccinology

Background:

• Persistent microbial infections arise from immune system evasion, genetic mutations, or host DNA integration.
• Defective host immunity and immune tolerance contribute significantly to chronic infections.
• Therapeutic vaccines offer a strategy to induce targeted immune responses against persistent microbes.

Purpose of the Study:

• To review current therapeutic vaccine categories for persistent infections.
• To discuss research prospects and the development of novel vaccines.
• To highlight strategies for overcoming microbial persistence and immune evasion.

Main Methods:

• Review of existing literature on therapeutic vaccines for microbial infections.
• Analysis of mechanisms underlying microbial persistence.
• Discussion of immunological approaches to vaccine development.

Main Results:

• Various therapeutic vaccine platforms have been developed.
• Understanding of microbial evasion strategies is crucial for vaccine design.
• Challenges remain in inducing robust and sustained immune responses.

Conclusions:

• Therapeutic vaccines hold promise for treating persistent microbial infections.
• Further research is needed to develop more effective and broadly applicable vaccines.
• Novel vaccine strategies are essential to combat evolving microbial threats.